Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 7Unspecified Adult Solid Tumor, Protocol Specific 4Lymphoma, Mantle-Cell 4Colorectal Neoplasms 4Rectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Lymphocytic, Chronic, B-Cell 3Glioblastoma 3Waldenstrom Macroglobulinemia 2Squamous Cell Carcinoma of Head and Neck 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Neoplasms 2Multiple Myeloma 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Extranodal NK-T-Cell 2Leukemia, Prolymphocytic 2Leukemia, Myeloid, Acute 2Leukemia 2Hodgkin Disease 2Gliosarcoma 2Glioma 2Congenital Abnormalities 2Colonic Neoplasms 2Burkitt Lymphoma 2

Interventions

Cyclophosphamide 8fludarabine phosphate 6fludarabine 5Bendamustine Hydrochloride 4Busulfan 3AP 1903 reagent 3pembrolizumab 2Tacrolimus 2Mycophenolic Acid 2thymoglobulin 1pimonidazole 1palbociclib 1ibritumomab tiuxetan 1Valsartan 1Telemedicine 1Surveys and Questionnaires 1Rivaroxaban 1Rituximab 1Radiotherapy 1Plasmalyte A 1Pharmacogenomic Testing 1Melphalan 1Hydroxychloroquine 1Etoposide 1Dimethyl Sulfoxide 1Cytarabine 1Carmustine 1Bone Marrow Transplantation 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Immune System Diseases × Pharmacogenomic Testing × Clear all
NCT02670564 2019-04-16

ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)

Swiss Pediatric Oncology Group

Phase 4 Unknown
1,000 enrolled
LymphoidOther hematologic neoplasm

Immune System Diseases, Immunoproliferative Disorders, Leukemia, Leukemia, Lymphoid, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡